Skip to content

Air Q Laryngeal Airway Versus the AmbuAura Gain as a Conduit for Endotracheal Intubation

Air Q Intubating Laryngeal Airway (Air QILA) Versus the AmbuAura Gain as a Conduit for Endotracheal Intubation Assisted by Tube Exchanger, a Randomized Comparative Study.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05607433
Enrollment
44
Registered
2022-11-07
Start date
2022-11-30
Completion date
2022-12-31
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Difficult Intubation

Keywords

assisted intubation

Brief summary

The study aims to compare the efficacy of the Ambu AuraGain to that of the Air Q ILA as a conduit for endotracheal intubation assisted by tube exchanger. The comparison will be in terms of total intubation time, success rate of insertion of the tube exchanger as well as endotracheal intubation and complications.

Detailed description

Very few studies discussed assisted endotrachealc intubation using certain tools as bougie through the Air Q ILA . the hypothesis in this study is that the use of flexible, small calibre tube exchanger introduced through both supraglottic devices into the trachea as guidance for endotracheal intubation, will have shorter intubation time with the Ambu AuraGain than the Air Q ILA and less complications in both devices.

Interventions

DEVICEcook ®Airway Exchanger Catheter

A tube exchanger is a small calibre , flexible tube used to guide endotracheal intubation through a supraglottic device.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Masking description

only participants will be masked

Intervention model description

Randomized comparative study

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Age : 18 to 60 * ASA physical status 1 and 2 * body weight less than 90 kilos * Ganzouri airway score less than or equal to 3.

Exclusion criteria

* Active respiratory or cardiac disease * Any expected airway difficulties * Craniofacial abnormalities or fractures * patients with abnormal coagulation profile

Design outcomes

Primary

MeasureTime frameDescription
Total endotracheal intubation timetime of tube exchanger insertion and endotracheal tube insertiontube exchanger intubation time plus endotracheal intubation time

Secondary

MeasureTime frameDescription
success rate of endotracheal intubation1 second after insertion tube exchanger until successful endotracheal intubationincidence of successful endotracheal intubation
Tube exchanger insertion timefrom disconnection of the supraglottic device from ventilator to successful insertion of tube exchanger in tracheatime from disconnection of the supraglottic device from ventilator to successful insertion of tube exchanger in trachea

Other

MeasureTime frameDescription
postoperative hoarseness of voice2 hours postoperativechange of voice

Countries

Egypt

Contacts

Primary ContactHoda Alrify
hodazakariasaleh@outlook.com002 01004226722

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026